Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dhanuka Laboratories is a prominent Indian pharmaceutical company that specializes in the production of Active Pharmaceutical Ingredients (APIs) and advanced drug intermediates. The company is a leading manufacturer in the Cephalosporin category, with a product portfolio featuring widely used antibiotics such as Cefixime, Cefpodoxime Proxetil, and Cefdinir. Dhanuka Laboratories operates sophisticated manufacturing units in India that adhere to Good Manufacturing Practice (GMP) standards, ensuring high-quality output for global markets. As a key player in the synthetic chemistry space, the company provides essential components to formulation manufacturers worldwide, supporting the treatment of various infectious diseases. The company is part of the diversified Dhanuka Group and maintains a strong focus on research and development to optimize chemical processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dhanuka Laboratories.